Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1

Journal of Virology

Volumn 74, Issue 20, 2000, Pages 9594-9600

  Schramm, B ^a   Penn, M L ^a   Palacios, E H ^a   Grant, R M ^a   Kirchhoff, F ^a   Goldsmith, M A ^a  

^a GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RECEPTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN TISSUE; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; STRAIN DIFFERENCE; T LYMPHOCYTE; VIRUS PATHOGENESIS; VIRUS VIRULENCE;

CD4-POSITIVE T-LYMPHOCYTES; HIV-1; HIV-2; HUMAN; LYMPHOID TISSUE; RECEPTORS, CCR5; RECEPTORS, CXCR4; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VIRULENCE;

EID: 0033814714     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.20.9594-9600.2000     Document Type: Article

References (41)

1. Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency
2. Chemokine receptors as HIV-1 coreceptors: Roles in viral entry, tropism, and disease
3. Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection
4. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
5. Biologic heterogeneity of human immunodeficiency virus type 2 (HIV-2) strains
6. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency vires type 1
7. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
8. Genetic characterization of new West African simian immunodeficiency virus SIVsm: Geographic clustering of household-derived SIV strains with human immunodeficiency virus type 2 subtypes and genetically diverse viruses from a single feral sooty mangabey troop
9. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-celltropic isolates: Definition of critical amino acids involved in cell tropism
10. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals
11. Expression cloning of new receptors used by simian and human immunodeficiency viruses
12. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins
13. Isolation of a T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys)
14. Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology
15. Infection of human tonsil histocultures: A model for HIV pathogenesis
16. + T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1
17. Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue
18. Coreceptor usage of human immunodeficiency vires type 2 primary isolates and biological clones is broad and does not correlate with their syncytium-inducing capacities
19. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs
20. + cells is faster in HIV-1 than in HIV-2 infection
21. Brief report: Infection of a laboratory worker with simian immunodeficiency virus
22. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry
23. West African HIV-2-related human retrovirus with attenuated cytopathicity
24. Molecular characterization of an attenuated human immunodeficiency virus type 2 isolate
25. Reduced rate of disease development after HIV-2 infection as compared to HIV-1
26. A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4
27. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage
28. Genetically divergent of human immunodeficiency virus type 2 use multiple coreceptors for viral entry
29. CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue
30. Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo
31. Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2
32. 9-Year HIV-2-associated mortality in an urban community in Bissau, west Africa
33. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression
34. Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease
35. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: Progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population
36. Biological and molecular variability of human immunodeficiency virus type 2 isolates from The Gambia
37. Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2
38. Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop
39. G protein-coupled receptors in HIV and SIV entry: New perspectives on lentivirus-host interactions and on the utility of animal models
40. HIV-2-infected patients survive longer than HIV-1-infected patients
41. HIV-2 and T cell recognition